This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Raw JSON (canonical form + also see JSON Format Specification)
Oral Chemotherapy - Myleran
{ "resourceType": "MedicationAdministration", "id": "medadmin0310", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Myleran 2mg tablet, film coated</span></p></blockquote><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>effective</b>: 16 Jan. 2015, 8:03:00 am --> 16 Jan. 2015, 12:03:00 pm</p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></td></tr></table><p><b>request</b>: <a>Generated Summary: id: 12345689 (OFFICIAL); status: active; intent: order; Myleran 2mg tablet; authoredOn: 2015-01-15; <span>Chronic myeloid Leukemia (disorder)</span></a></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</td><td><span>Oral route (qualifier value)</span></td><td>6 mg</td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0304", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "76388-713-25", "display": "Myleran 2mg tablet, film coated" } ] } } ], "status": "completed", "medicationReference": { "reference": "#med0304" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "effectivePeriod": { "start": "2015-01-15T22:03:00+01:00", "end": "2015-01-16T02:03:00+01:00" }, "performer": [ { "actor": { "reference": "Practitioner/f007", "display": "Patrick Pump" } } ], "request": { "reference": "MedicationRequest/medrx0306" }, "dosage": { "text": "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL", "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "26643006", "display": "Oral route (qualifier value)" } ] }, "dose": { "value": 6, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.